Logo image
In non-critically ill patients with COVID-19, therapeutic anticoagulation improved survival to discharge without organ support
Journal article   Peer reviewed

In non-critically ill patients with COVID-19, therapeutic anticoagulation improved survival to discharge without organ support

Anthony A Donato
Annals of internal medicine, v 174(12), pp JC134-JC135
Dec 2021
PMID: 34871053

Abstract

Anticoagulants - therapeutic use COVID-19 Heparin Humans Patient Discharge SARS-CoV-2
Lawler PR, Goligher EC, Berger JS, et al. N Engl J Med. 2021;385:790-802. 34351721.

Metrics

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Web of Science research areas
Medicine, General & Internal
Logo image